Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990000596> ?p ?o ?g. }
- W1990000596 endingPage "16924" @default.
- W1990000596 startingPage "16909" @default.
- W1990000596 abstract "We aimed to evaluate the in vitro effects of yerba maté, YGD (a herbal preparation containing yerba maté, guarana and damiana), and resveratrol on adipogenesis. The anti-adipogenic effects of yerba mate, YGD, resveratrol and YGD + resveratrol and yerba mate + resveratrol combinations were evaluated in 3T3-L1 cells by Oil Red staining, cellular triglyceride content, and PCR quantitative array. The results demonstrated that all of the tested compounds inhibited adipogenesis. Yerba maté extract significantly down-regulated the expression of genes that play an important role in regulating adipogenesis, such as Adig, Axin, Cebpa, Fgf10, Lep, Lpl, and Pparγ2. In addition, these genes, YGD also repressed Bmp2, Ccnd1, Fasn, and Srebf1. Resveratrol also modulated the expression of Adig, Bmp2, Ccnd1, C/EBPα, Fasn, Fgf10, Lep, Lpl, and Pparγ2. Moreover, resveratrol repressed Cebpb, Cdk4, Fgf2, and Klf15. The yerba maté extract and YGD up-regulated the expression of genes involved in inhibiting adipogenesis, such as Dlk-1, Klf2, and Ucp1. Resveratrol also induced the expression of Klf2 and Ucp1. In addition resveratrol modulated the Ddit3, Foxo1, Sirt1, and Sirt2. The combined effects of these compounds on gene expression showed similar results observed from individual treatments. Our data indicates that the synergy between the compounds favors the inhibition of adipogenesis." @default.
- W1990000596 created "2016-06-24" @default.
- W1990000596 creator A5019714972 @default.
- W1990000596 creator A5043592425 @default.
- W1990000596 creator A5058284453 @default.
- W1990000596 creator A5073621479 @default.
- W1990000596 creator A5079631115 @default.
- W1990000596 creator A5080473323 @default.
- W1990000596 date "2014-10-21" @default.
- W1990000596 modified "2023-09-28" @default.
- W1990000596 title "Effects of Yerba maté, a Plant Extract Formulation (“YGD”) and Resveratrol in 3T3-L1 Adipogenesis" @default.
- W1990000596 cites W1940266816 @default.
- W1990000596 cites W1963966137 @default.
- W1990000596 cites W1966927325 @default.
- W1990000596 cites W1969408132 @default.
- W1990000596 cites W1974269714 @default.
- W1990000596 cites W1977731319 @default.
- W1990000596 cites W1983979341 @default.
- W1990000596 cites W1985208296 @default.
- W1990000596 cites W1987647107 @default.
- W1990000596 cites W1990413035 @default.
- W1990000596 cites W1991782854 @default.
- W1990000596 cites W1992550390 @default.
- W1990000596 cites W1994874483 @default.
- W1990000596 cites W1997801717 @default.
- W1990000596 cites W1998320082 @default.
- W1990000596 cites W2004625762 @default.
- W1990000596 cites W2008874873 @default.
- W1990000596 cites W2009347184 @default.
- W1990000596 cites W2012672094 @default.
- W1990000596 cites W2017084375 @default.
- W1990000596 cites W2020723945 @default.
- W1990000596 cites W2021951421 @default.
- W1990000596 cites W2022062435 @default.
- W1990000596 cites W2028782957 @default.
- W1990000596 cites W2030031808 @default.
- W1990000596 cites W2033048925 @default.
- W1990000596 cites W2035926347 @default.
- W1990000596 cites W2037035652 @default.
- W1990000596 cites W2039148546 @default.
- W1990000596 cites W2039464457 @default.
- W1990000596 cites W2039999119 @default.
- W1990000596 cites W2040445124 @default.
- W1990000596 cites W2040994429 @default.
- W1990000596 cites W2046206055 @default.
- W1990000596 cites W2046876726 @default.
- W1990000596 cites W2049730346 @default.
- W1990000596 cites W2051384977 @default.
- W1990000596 cites W2051863666 @default.
- W1990000596 cites W2054003772 @default.
- W1990000596 cites W2060046111 @default.
- W1990000596 cites W2064420317 @default.
- W1990000596 cites W2067644861 @default.
- W1990000596 cites W2071706440 @default.
- W1990000596 cites W2073998126 @default.
- W1990000596 cites W2076522247 @default.
- W1990000596 cites W2077243848 @default.
- W1990000596 cites W2089435895 @default.
- W1990000596 cites W2091605975 @default.
- W1990000596 cites W2094396324 @default.
- W1990000596 cites W2097681801 @default.
- W1990000596 cites W2098013763 @default.
- W1990000596 cites W2107793453 @default.
- W1990000596 cites W2108835302 @default.
- W1990000596 cites W2114350429 @default.
- W1990000596 cites W2116821733 @default.
- W1990000596 cites W2118644406 @default.
- W1990000596 cites W2119047246 @default.
- W1990000596 cites W2133481218 @default.
- W1990000596 cites W2136582080 @default.
- W1990000596 cites W2140037044 @default.
- W1990000596 cites W2143883376 @default.
- W1990000596 cites W2144411343 @default.
- W1990000596 cites W2147543478 @default.
- W1990000596 cites W2149749113 @default.
- W1990000596 cites W2151385330 @default.
- W1990000596 cites W2157860216 @default.
- W1990000596 cites W2165722123 @default.
- W1990000596 cites W2167588497 @default.
- W1990000596 cites W2169403756 @default.
- W1990000596 cites W4211007940 @default.
- W1990000596 doi "https://doi.org/10.3390/molecules191016909" @default.
- W1990000596 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6271528" @default.
- W1990000596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25338179" @default.
- W1990000596 hasPublicationYear "2014" @default.
- W1990000596 type Work @default.
- W1990000596 sameAs 1990000596 @default.
- W1990000596 citedByCount "20" @default.
- W1990000596 countsByYear W19900005962015 @default.
- W1990000596 countsByYear W19900005962016 @default.
- W1990000596 countsByYear W19900005962017 @default.
- W1990000596 countsByYear W19900005962018 @default.
- W1990000596 countsByYear W19900005962020 @default.
- W1990000596 countsByYear W19900005962021 @default.
- W1990000596 countsByYear W19900005962022 @default.
- W1990000596 countsByYear W19900005962023 @default.
- W1990000596 crossrefType "journal-article" @default.
- W1990000596 hasAuthorship W1990000596A5019714972 @default.